• Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis
  • Herpes Simplex Virus (HSV) 1 and 2 IgM
  • Cytochrome P450 2D6 (CYP2D6) Genotyping
  • Reticulin Antibody, IgA
  • Aripiprazole (Abilify), Serum
  • Alkaline Phosphatase (ALP), Serum
  • Gastrointestinal Parasite Pathogen Panel, Molecular
  • Alpha 2 Plasmin Inhibitor, Plasma
  • BDX-XL2, EarlyCDT®-Lung, Blood Test for Early Detection of Lung Cancer
  • Acute Myeloid Leukemia (AML), FISH, Bone Marrow
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Inhibin A and B, Tumor Marker
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Inhibin A and B, Tumor Marker
Medical Test

Turnaround Time
Access to Inhibin A and B, Tumor Marker is restricted.
Loading...